0001203311-23-000097.txt : 20230830
0001203311-23-000097.hdr.sgml : 20230830
20230830190839
ACCESSION NUMBER: 0001203311-23-000097
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230828
FILED AS OF DATE: 20230830
DATE AS OF CHANGE: 20230830
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DANSEY ROGER D
CENTRAL INDEX KEY: 0001741836
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-32405
FILM NUMBER: 231226455
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
CITY: BOTHELL
STATE: WA
ZIP: 98021
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Seagen Inc.
CENTRAL INDEX KEY: 0001060736
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 911874389
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4255274000
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER COMPANY:
FORMER CONFORMED NAME: SEATTLE GENETICS INC /WA
DATE OF NAME CHANGE: 20001116
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0508
4
2023-08-28
0
0001060736
Seagen Inc.
SGEN
0001741836
DANSEY ROGER D
21823 30TH DRIVE SE
BOTHELL
WA
98021
0
1
0
0
President, R&D & CMO
0
Common Stock
2023-08-28
4
A
0
1872
0.0
A
116813
D
Common Stock
2023-08-29
4
S
0
1016
206.0
D
115797
D
The performance criteria for these restricted stock units were met. These restricted stock units became fully vested on 8/28/2023.
Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
The sales reported in this Form 4 were effected pursuant to a written plan adopted on 11/13/2020 that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
By: /s/ Jennifer Prosba For: Roger D. Dansey
2023-08-30